Fig. 7From: Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systemsCytotoxicity of NK92 cells to HepG2 cells following treatment with efavirenz and efavirenz solid drug nanoparticles. NK92 cells were treated with either efavirenz aqueous solution (a) or efavirenz s (b) for 24 h before their cytotoxic capability was assessedBack to article page